110 related articles for article (PubMed ID: 35799867)
1. Possible different genotypes for human papillomavirus vaccination in lower middle-income countries towards cervical cancer elimination in 2030: a cross-sectional study.
Utami TW; Andrijono A; Putra A; Indarti J; Fleuren G; Jordanova E; Humairah I; Utomo A
Clin Exp Vaccine Res; 2022 May; 11(2):141-148. PubMed ID: 35799867
[TBL] [Abstract][Full Text] [Related]
2. Detection and genotyping of HPV-DNA through different types of diagnostic platforms in liquid-based cervical-cytology samples.
Cassani B; Soldano G; Finocchiaro D; Conti S; Bulfamante A; Lemorini G; Bulfamante G
Pathologica; 2018 Dec; 110(4):294-301. PubMed ID: 30799441
[TBL] [Abstract][Full Text] [Related]
3. The original SPF10 LiPA25 algorithm is more sensitive and suitable for epidemiologic HPV research than the SPF10 INNO-LiPA Extra.
Geraets DT; Struijk L; Kleter B; Molijn A; van Doorn LJ; Quint WG; Colau B
J Virol Methods; 2015 Apr; 215-216():22-9. PubMed ID: 25698462
[TBL] [Abstract][Full Text] [Related]
4. Evidence for Missing Positive Results for Human Papilloma Virus 45 (HPV-45) and HPV-59 with the SPF
van Eer K; Leussink S; Severs TT; van Marm-Wattimena N; Woestenberg PJ; Bogaards JA; King AJ
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32907991
[TBL] [Abstract][Full Text] [Related]
5. An epidemiological study assessing the prevalence of human papillomavirus types in women in the Kingdom of Bahrain.
Moosa K; Alsayyad AS; Quint W; Gopala K; DeAntonio R
BMC Cancer; 2014 Dec; 14():905. PubMed ID: 25466757
[TBL] [Abstract][Full Text] [Related]
6. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
Cornall AM; Saville M; Pyman J; Callegari ET; Tan FH; Brotherton JML; Malloy MJ; Tabrizi SN; Wrede CD; Garland SM;
Vaccine; 2020 Sep; 38(40):6304-6311. PubMed ID: 32736938
[TBL] [Abstract][Full Text] [Related]
7. Targeted next generation sequencing panel for HPV genotyping in cervical cancer.
Lippert J; Bønløkke S; Utke A; Knudsen BR; Sorensen BS; Steiniche T; Stougaard M
Exp Mol Pathol; 2021 Feb; 118():104568. PubMed ID: 33171155
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of vaccine and non-vaccine human papillomavirus types among women in Accra and Kumasi, Ghana: a cross-sectional study.
Debrah O; Agyemang-Yeboah F; Donkoh ET; Asmah RH
BMC Womens Health; 2021 Oct; 21(1):372. PubMed ID: 34702246
[TBL] [Abstract][Full Text] [Related]
9. HPV Genotypes distribution in Indian women with and without cervical carcinoma: Implication for HPV vaccination program in Odisha, Eastern India.
Senapati R; Nayak B; Kar SK; Dwibedi B
BMC Infect Dis; 2017 Jan; 17(1):30. PubMed ID: 28056826
[TBL] [Abstract][Full Text] [Related]
10. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
Mihretie GN; Liyeh TM; Ayele AD; Belay HG; Yimer TS; Miskr AD
Reprod Health; 2022 Jun; 19(1):136. PubMed ID: 35689288
[TBL] [Abstract][Full Text] [Related]
11. Epidemiological Profile of Human Papillomavirus in a Healthcare Center in Portugal: Implications for Public Health Policies.
Luz Pereira A; Chaves Beça D; Buchner Sousa M; Vaz Pinto M; Bento D; Leal I; Bandeira M
Cureus; 2024 Mar; 16(3):e57023. PubMed ID: 38545422
[TBL] [Abstract][Full Text] [Related]
12. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic.
Perrons C; Kleter B; Jelley R; Jalal H; Quint W; Tedder R
J Med Virol; 2002 Jun; 67(2):246-52. PubMed ID: 11992586
[TBL] [Abstract][Full Text] [Related]
13. Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
Brotherton JML; Tabrizi SN; Phillips S; Pyman J; Cornall AM; Lambie N; Anderson L; Cummings M; Payton D; Scurry JP; Newman M; Sharma R; Saville M; Garland SM
Int J Cancer; 2017 Oct; 141(8):1576-1584. PubMed ID: 28677147
[TBL] [Abstract][Full Text] [Related]
14. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract][Full Text] [Related]
15. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.
Geraets D; Alemany L; Guimera N; de Sanjose S; de Koning M; Molijn A; Jenkins D; Bosch X; Quint W;
J Pathol; 2012 Dec; 228(4):534-43. PubMed ID: 22711526
[TBL] [Abstract][Full Text] [Related]
16. Human Papillomavirus Genotype Distribution in Invasive Cervical Cancer in Pakistan.
Loya A; Serrano B; Rasheed F; Tous S; Hassan M; Clavero O; Raza M; De Sanjosé S; Bosch FX; Alemany L
Cancers (Basel); 2016 Jul; 8(8):. PubMed ID: 27483322
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus prevalence and type distribution among women attending routine gynecological examinations in Saudi Arabia.
AlObaid A; Al-Badawi IA; Al-Kadri H; Gopala K; Kandeil W; Quint W; Al-Aker M; DeAntonio R
BMC Infect Dis; 2014 Dec; 14():643. PubMed ID: 25496614
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
19. Post hoc analysis of the PATRICIA randomized trial of the efficacy of human papillomavirus type 16 (HPV-16)/HPV-18 AS04-adjuvanted vaccine against incident and persistent infection with nonvaccine oncogenic HPV types using an alternative multiplex type-specific PCR assay for HPV DNA.
Struyf F; Colau B; Wheeler CM; Naud P; Garland S; Quint W; Chow SN; Salmerón J; Lehtinen M; Del Rosario-Raymundo MR; Paavonen J; Teixeira JC; Germar MJ; Peters K; Skinner SR; Limson G; Castellsagué X; Poppe WA; Ramjattan B; Klein TD; Schwarz TF; Chatterjee A; Tjalma WA; Diaz-Mitoma F; Lewis DJ; Harper DM; Molijn A; van Doorn LJ; David MP; Dubin G;
Clin Vaccine Immunol; 2015 Feb; 22(2):235-44. PubMed ID: 25540273
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and genotype distribution of cervical human papillomavirus (HPV) among women in urban Tianjin, China.
Chen X; Wallin KL; Duan M; Gharizadeh B; Zheng B; Qu P
J Med Virol; 2015 Nov; 87(11):1966-72. PubMed ID: 26073652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
